Terconazole, an Azole Antifungal Drug, Increases Cytotoxicity in Antimitotic Drug-Treated Resistant Cancer Cells with Substrate-Specific P-gp Inhibitory Activity.

Lee, Ji Sun; Oh, Yunmoon; Park, Jae Hyeon; Kyung, So Young; Kim, Hyung Sik; Yoon, Sungpil

Lee, Ji Sun; Oh, Yunmoon; Park, Jae Hyeon; Kyung, So Young; Kim, Hyung Sik; Yoon, Sungpil.

Afiliação

Lee JS; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
Oh Y; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
Park JH; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
Kyung SY; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
Kim HS; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.
Yoon S; School of Pharmacy, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon 16419, Korea.

Int J Mol Sci ; 23(22)2022 Nov 09.

Article em En | MEDLINE | ID: mdl-36430288

Assuntos

Antimitóticos; Neoplasias; Humanos; Antimitóticos/farmacologia; Antifúngicos/farmacologia; Resistencia a Medicamentos Antineoplásicos; Linhagem Celular Tumoral; Vincristina/farmacologia; Membro 1 da Subfamília B de Cassetes de Ligação de ATP/genética

Palavras-chave

P-gp; azole antifungal drugs; cancer; co-treatment; drug resistance; terconazole

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antimitóticos / Neoplasias Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google